Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Asset Utilization Ratio (2021 - 2025)

Kiniksa Pharmaceuticals International's Asset Utilization Ratio history spans 5 years, with the latest figure at 0.92 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 23.2% year-over-year to 0.92; the TTM value through Dec 2025 reached 0.92, up 23.2%, while the annual FY2025 figure was 1.01, 31.83% up from the prior year.
  • Asset Utilization Ratio reached 0.92 in Q4 2025 per KNSA's latest filing, up from 0.87 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.92 in Q4 2025 to a low of 0.02 in Q4 2022.
  • Average Asset Utilization Ratio over 5 years is 0.49, with a median of 0.54 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: crashed 86.3% in 2022, then skyrocketed 2362.26% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.16 in 2021, then plummeted by 86.3% to 0.02 in 2022, then surged by 2362.26% to 0.54 in 2023, then soared by 39.17% to 0.75 in 2024, then increased by 23.2% to 0.92 in 2025.
  • Per Business Quant, the three most recent readings for KNSA's Asset Utilization Ratio are 0.92 (Q4 2025), 0.87 (Q3 2025), and 0.84 (Q2 2025).